Corrigendum to FEV1 Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function [The Journal of Pediatrics (2016) 116–121] (The Journal of Pediatrics (2016) 169 (116–121.e2), (S0022347615009750), (10.1016/j.jpeds.2015.08.042))

Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

The authors regret that in this paper predicting lung function decline we used change in best %pred FEV1 from baseline to follow-up as the outcome. In retrospect, we should have used an outcome measure that did not include baseline lung function values. As a result, this calls into question whether the median deviation from the best %pred FEV1 has the greatest predictive value for subsequent decline in lung function. Unfortunately, the data are not available to repeat the analysis to resolve this question. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)265
Number of pages1
JournalJournal of Pediatrics
Volume255
DOIs
StatePublished - Apr 2023

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Corrigendum to FEV1 Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function [The Journal of Pediatrics (2016) 116–121] (The Journal of Pediatrics (2016) 169 (116–121.e2), (S0022347615009750), (10.1016/j.jpeds.2015.08.042))'. Together they form a unique fingerprint.

Cite this